{"altmetric_id":22082399,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":3},"news":{"unique_users_count":2,"unique_users":["wall_street_online_denmark","finanz_nachrichten"],"posts_count":3}},"citation":{"abstract":"In the present study we compared the clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury. A total of 150 patients were enrolled in the present study and were divided into two groups with 75 patients in each group, receiving baclofen or tolperisone, respectively. We used Modified Ashworth Scale, Medical research council scale, Barthel Index, and Coefficient of efficacy to measure clinical efficacy. After 6-week treatment, both groups demonstrated significant improvement in muscle tone, muscle strength and functional outcome (Group I, 1.55\u00a0\u00b1\u00a00.053, 2.79\u00a0\u00b1\u00a00.032, 59.31\u00a0\u00b1\u00a01.32; Group II, 1.57\u00a0\u00b1\u00a00.053, 3.04\u00a0\u00b1\u00a00.032, 73\u00a0\u00b1\u00a01.32 respectively). There was no significant difference regarding improvement in muscle tone and muscle strength between the two groups (Group I, 1.055\u00a0\u00b1\u00a00.053 vs Group II, 1.57\u00a0\u00b1\u00a00.053; Group I, 2.79\u00a0\u00b1\u00a00.032 vs Group II, 3.04\u00a0\u00b1\u00a00.032, p\u00a0>\u00a00.05). However, the improvement in functional outcomes was greater in group II as compared to that in group I (Group I, 59.31\u00a0\u00b1\u00a01.32 vs Group II, 73\u00a0\u00b1\u00a01.32, p\u00a0<\u00a00.05). In addition, overall efficacy coefficient was greater for group II as compared to group I (Group I, 3.6\u00a0vs Group II, 2.3, p\u00a0<\u00a00.05). Group I had more side effects compared to Group II. Compared to baclofen, tolperisone offers greater improvement in activities of daily living compared to baclofen.","altmetric_jid":"4f6fa6373cf058f610008892","authors":["Dejun Luo","Guoyong Wu","Yong Ji","Zhaoyao Zhang","Fayou He","Xiaping Mou","Qingmao Zhu","Bo Yang"],"doi":"10.1016\/j.jsps.2017.04.041","first_seen_on":"2017-07-18T08:36:34+00:00","issns":["13190164"],"issue":"4","journal":"Saudi Pharmaceutical Journal","last_mentioned_on":1500380505,"links":["https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5447437\/"],"pmcid":"PMC5447437","pmid":"28579907","pubdate":"2017-05-01T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"655","title":"The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury","type":"article","volume":"25","mendeley_url":"http:\/\/www.mendeley.com\/research\/comparative-study-clinical-efficacy-safety-baclofen-vs-tolperisone-spasticity-caused-spinal-cord-inj"},"altmetric_score":{"score":14,"score_history":{"1y":14,"6m":14,"3m":14,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":14},"context_for_score":{"all":{"total_number_of_other_articles":8229472,"mean":6.9710874477773,"rank":600973,"this_scored_higher_than_pct":92,"this_scored_higher_than":7620993,"rank_type":"exact","sample_size":8229472,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":163880,"mean":11.676118196962,"rank":19448,"this_scored_higher_than_pct":88,"this_scored_higher_than":144308,"rank_type":"exact","sample_size":163880,"percentile":88},"this_journal":{"total_number_of_other_articles":144,"mean":2.7251328671329,"rank":8,"this_scored_higher_than_pct":94,"this_scored_higher_than":136,"rank_type":"exact","sample_size":144,"percentile":94},"similar_age_this_journal_3m":{"total_number_of_other_articles":3,"mean":6.575,"rank":1,"this_scored_higher_than_pct":66,"this_scored_higher_than":2,"rank_type":"exact","sample_size":3,"percentile":66}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":2,"Nursing and Health Professions":1}}}},"posts":{"news":[{"title":"Published data confirms the advantage of tolperisone in comparison to another muscle relaxant","url":"http:\/\/ct.moreover.com\/?a=31242099486&p=1pl&v=1&x=_K8MmVrupv97pGrSjZNcfw","license":"public","citation_ids":[22082399],"posted_on":"2017-07-18T08:32:01+00:00","summary":"Business news for the stock market Wien (pta014\/18.07.2017\/10:30) - Recently published data confirm the advantage of tolperisone in comparison to another muscle relaxant in patients with spasticity Sanochemia Pharmazeutika AG, Vienna (ISIN\u2026","author":{"name":"Wall Street Online Denmark","url":"http:\/\/www.wallstreet-online.de","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/836\/normal\/Screen_Shot_2016-01-27_at_11.09.05.png?1453892964"}},{"title":"Ver\u00f6ffentlichte Daten best\u00e4tigen den Vorteil von Tolperison im Vergleich zu anderen Muskelrelaxans","url":"http:\/\/ct.moreover.com\/?a=31244094409&p=1pl&v=1&x=VO5nZdsH6ATdAxU69HKRhw","license":"public","citation_ids":[22082399],"posted_on":"2017-07-18T12:21:45+00:00","summary":"\/13:12) - K\u00fcrzlich ver\u00f6ffentlichte Daten best\u00e4tigen den Vorteil von Tolperison im Vergleich zu einem anderen Muskelrelaxans bei Patienten mit Spastizit\u00e4t Wien, 19.","author":{"name":"Wall Street Online Denmark","url":"http:\/\/www.wallstreet-online.de","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/836\/normal\/Screen_Shot_2016-01-27_at_11.09.05.png?1453892964"}},{"title":"PTA-News: SANOCHEMIA Pharmazeutika AG: Ver\u00f6ffentlichte Daten best\u00e4tigen den Vorteil von Tolperison im Vergleich zu anderen Muskelrelaxans","url":"http:\/\/ct.moreover.com\/?a=31243768406&p=1pl&v=1&x=Zy-ZR9UoRgzJ2Vd6MMvTgA","license":"public","citation_ids":[22082399],"posted_on":"2017-07-18T11:42:00+00:00","summary":"Unternehmensmitteilung f\u00fcr den Kapitalmarkt Wien (pta022\/18.07.2017\/13:12) - K\u00fcrzlich ver\u00f6ffentlichte Daten best\u00e4tigen den Vorteil von Tolperison im Vergleich zu einem anderen Muskelrelaxans bei Pa...","author":{"name":"Finanz Nachrichten","url":"http:\/\/www.finanznachrichten.de","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/853\/normal\/Screen_Shot_2016-01-27_at_11.54.22.png?1453895724"}}]}}